IC
TMO icon

Inscription Capital’s Thermo Fisher Scientific TMO Stock Holding History

Inscription Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$617K Buy
1,231
+387
+46% +$186K 0.05% 330
2026
Q1 		$415K Sell
844
-45
-5% -$24.4K 0.04% 410
2025
Q4 		$515K Sell
889
-87
-9% -$49.2K 0.05% 353
2025
Q3 		$473K Buy
976
+54
+6% +$25.1K 0.05% 371
2025
Q2 		$374K Sell
922
-115
-11% -$48.1K 0.05% 296
2025
Q1 		$603K Buy
+1,037
New +$562K 0.1% 151
2024
Q3 		$611K Sell
988
-19
-2% -$11.2K 0.09% 163
2024
Q2 		$557K Sell
1,007
-30
-3% -$17.2K 0.09% 164
2024
Q1 		$603K Buy
1,037
+60
+6% +$33.7K 0.1% 151
2023
Q4 		$519K Buy
977
+270
+38% +$131K 0.14% 117
2023
Q3 		$358K Sell
707
-22
-3% -$11.7K 0.12% 129
2023
Q2 		$380K Sell
729
-756
-51% -$408K 0.12% 130
2023
Q1 		$856K Sell
1,485
-118
-7% -$66.5K 0.23% 81
2022
Q4 		$883K Sell
1,603
-435
-21% -$231K 0.3% 74
2022
Q3 		$1.03M Sell
2,038
-1,610
-44% -$901K 0.29% 62
2022
Q2 		$1.98M Buy
3,648
+1,567
+75% +$863K 0.36% 59
2022
Q1 		$1.23M Sell
2,081
-417
-17% -$240K 0.35% 66
2021
Q4 		$1.67M Buy
2,498
+2
+0.1% +$1.25K 0.46% 53
2021
Q3 		$1.43M Sell
2,496
-324
-11% -$178K 0.45% 60
2021
Q2 		$1.42M Buy
2,820
+168
+6% +$79.3K 0.16% 108
2021
Q1 		$1.21M Sell
2,652
-73
-3% -$34.8K 0.41% 66
2020
Q4 		$1.27M Buy
2,725
+1,804
+196% +$846K 0.49% 58
2020
Q3 		$407K Hold
921
– – 0.18% 105
2020
Q2 		$334K Buy
921
+120
+15% +$40.2K 0.18% 94
2020
Q1 		$227K Buy
801
+60
+8% +$18.9K 0.15% 107
2019
Q4 		$241K Sell
741
-40
-5% -$12.1K 0.11% 131
2019
Q3 		$228K Hold
781
– – 0.13% 131
2019
Q2 		$210K Sell
781
-266
-25% -$73.3K 0.16% 99
2019
Q1 		$287K Sell
1,047
-286
-21% -$71.2K 0.15% 92
2018
Q4 		$299K Buy
+1,333
New +$313K 0.17% 95

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Inscription Capital's TMO Position: Q2 2026 in Review

Inscription Capital increased its Thermo Fisher Scientific (TMO) stake by 46% in Q2 2026, buying an estimated $186K and bringing the position to 1,231 shares worth $617K. The position accounts for 0.05% of the portfolio, ranked #330.

Inscription Capital first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.98M in Q2 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Inscription Capital held 1,231 shares of Thermo Fisher Scientific worth $617K as of Q2 2026.
  • Inscription Capital bought 387 Thermo Fisher Scientific shares in Q2 2026, an estimated $186K.
  • Thermo Fisher Scientific made up 0.05% of Inscription Capital's portfolio in Q2 2026, its #330 holding.
  • Inscription Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Inscription Capital's Thermo Fisher Scientific position peaked at $1.98M in Q2 2022.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.